Cohort profile: China healthy aging cohort study (China-Aging).

IF 3.4 3区 医学 Q2 NEUROSCIENCES
Jie Chang, Yue Wu, Yiwei Zhao, Xue Gao, Yiwen Xing, Zhibin Wang, Qi Qin, Wenqing Ni, Yangwei Ying, Xiaoyan Liu, Lumin Leng, Hong Zhou, Lina Ma, Yansu Guo, Guoping Peng, Yong You, Jindong Ding Petersen, Jian Xu, Yi Tang
{"title":"Cohort profile: China healthy aging cohort study (China-Aging).","authors":"Jie Chang, Yue Wu, Yiwei Zhao, Xue Gao, Yiwen Xing, Zhibin Wang, Qi Qin, Wenqing Ni, Yangwei Ying, Xiaoyan Liu, Lumin Leng, Hong Zhou, Lina Ma, Yansu Guo, Guoping Peng, Yong You, Jindong Ding Petersen, Jian Xu, Yi Tang","doi":"10.1177/13872877251360028","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundAs China undergoes a demographic transition towards an aging society, the prevalence and incidence of age-related disabilities, Alzheimer's disease, and various geriatric syndromes are steadily rising.ObjectiveThe China Healthy Aging Cohort Study (China-Aging) aims to investigate the prevalence and associated risk factors of disability and cognitive impairment, and to develop predictive models for these conditions by combining traditional risk factors with artificial intelligence-derived metrics (such as gait, speech, vision, etc.).MethodsThe China-Aging cohort consists of community-dwelling participants aged 60 years and older from Beijing, Hangzhou, Shenzhen, and Haikou. The baseline recruitment was from May 16, 2022 to March 19, 2025, with study participants primarily from urban areas. Follow-up assessment of the cohort will occur every 1-3 years from the baseline.ResultsAmong 6283 participants who completed the baseline evaluation (mean age 70.6 years, SD 6.3), 3775 (60.1%) were women. The overall prevalence of disability, cognitive impairment, frailty, depression, and sarcopenia were 17.8%, 18.5%, 5.9%, 7.1%, and 5.7%, respectively. The prevalence of disability in the Beijing cohort was higher than in other cohorts (Beijing: 35.6%, Hangzhou: 6.5%, Shenzhen: 6.8%, Haikou: 10.9%) and the prevalence of cognitive impairment in the Haikou cohort was higher than in other cohorts (Beijing: 9.5%, Hangzhou: 7.9%, Shenzhen: 16.2%, Haikou: 45.5%).ConclusionsThe prevalence of disability and cognitive impairment is relatively high, and notable regional difference exists in China. China-Aging cohort provides crucial evidence for the precise prevention and management of disability, cognitive impairment, and other geriatric syndromes in promoting active and healthy aging.</p>","PeriodicalId":14929,"journal":{"name":"Journal of Alzheimer's Disease","volume":" ","pages":"13872877251360028"},"PeriodicalIF":3.4000,"publicationDate":"2025-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Alzheimer's Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13872877251360028","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundAs China undergoes a demographic transition towards an aging society, the prevalence and incidence of age-related disabilities, Alzheimer's disease, and various geriatric syndromes are steadily rising.ObjectiveThe China Healthy Aging Cohort Study (China-Aging) aims to investigate the prevalence and associated risk factors of disability and cognitive impairment, and to develop predictive models for these conditions by combining traditional risk factors with artificial intelligence-derived metrics (such as gait, speech, vision, etc.).MethodsThe China-Aging cohort consists of community-dwelling participants aged 60 years and older from Beijing, Hangzhou, Shenzhen, and Haikou. The baseline recruitment was from May 16, 2022 to March 19, 2025, with study participants primarily from urban areas. Follow-up assessment of the cohort will occur every 1-3 years from the baseline.ResultsAmong 6283 participants who completed the baseline evaluation (mean age 70.6 years, SD 6.3), 3775 (60.1%) were women. The overall prevalence of disability, cognitive impairment, frailty, depression, and sarcopenia were 17.8%, 18.5%, 5.9%, 7.1%, and 5.7%, respectively. The prevalence of disability in the Beijing cohort was higher than in other cohorts (Beijing: 35.6%, Hangzhou: 6.5%, Shenzhen: 6.8%, Haikou: 10.9%) and the prevalence of cognitive impairment in the Haikou cohort was higher than in other cohorts (Beijing: 9.5%, Hangzhou: 7.9%, Shenzhen: 16.2%, Haikou: 45.5%).ConclusionsThe prevalence of disability and cognitive impairment is relatively high, and notable regional difference exists in China. China-Aging cohort provides crucial evidence for the precise prevention and management of disability, cognitive impairment, and other geriatric syndromes in promoting active and healthy aging.

队列简介:中国健康老龄化队列研究(China- aging)。
随着中国人口结构向老龄化社会过渡,与年龄有关的残疾、阿尔茨海默病和各种老年综合征的患病率和发病率正在稳步上升。目的中国健康老龄化队列研究(China-Aging)旨在调查残疾和认知障碍的患病率及其相关危险因素,并将传统危险因素与人工智能衍生指标(如步态、语言、视觉等)相结合,建立这些疾病的预测模型。方法中国老龄化队列由来自北京、杭州、深圳和海口的60岁及以上社区居民组成。基线招募时间为2022年5月16日至2025年3月19日,研究参与者主要来自城市地区。从基线开始,每1-3年对队列进行随访评估。在6283名完成基线评估的参与者(平均年龄70.6岁,SD 6.3)中,3775名(60.1%)为女性。残疾、认知障碍、虚弱、抑郁和肌肉减少症的总体患病率分别为17.8%、18.5%、5.9%、7.1%和5.7%。北京队列的残疾患病率高于其他队列(北京:35.6%,杭州:6.5%,深圳:6.8%,海口:10.9%),海口队列的认知障碍患病率高于其他队列(北京:9.5%,杭州:7.9%,深圳:16.2%,海口:45.5%)。结论中国残疾和认知功能障碍患病率较高,且存在显著的地区差异。中国老龄化队列研究为精准预防和管理残疾、认知障碍和其他老年综合征,促进积极健康老龄化提供了重要依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease 医学-神经科学
CiteScore
6.40
自引率
7.50%
发文量
1327
审稿时长
2 months
期刊介绍: The Journal of Alzheimer''s Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer''s disease. The journal publishes research reports, reviews, short communications, hypotheses, ethics reviews, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer''s disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信